Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Test for Abnormal Toxicity


The scientific validity and rationale of the test for Abnormal Toxicity has been the subject of debate for some time in Europe. The test was originally developed for detecting external contaminants in biological products, but over time the introduction of Good Manufacturing Practices and the use of appropriate and stringent Quality Control measures have rendered their use less necessary. Current scientific evidence suggests that, in light of such debatable relevance, the omission of the test for abnormal toxicity would not compromise the safety of biological medicines.

The European Pharmacopeia is considering the possible deletion from the European Pharmacopoeia. The European Pharmacopoeia Commission is seeking public feedback on its proposal to remove the requirements for a test for abnormal toxicity from 49 monographs of the European Pharmacopoeia (Ph. Eur.).

This consultation will run until June 2017 for all users, and will be extended until August for National Pharmacopoeia Authorities.

See: EDQM



Posted by Dr. Tim Sandle


This post first appeared on Pharmaceutical Microbiology, please read the originial post: here

Share the post

Test for Abnormal Toxicity

×

Subscribe to Pharmaceutical Microbiology

Get updates delivered right to your inbox!

Thank you for your subscription

×